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Objective To determine risk of Down syndrome (DS) in multiple
relative to singleton pregnancies, and compare prenatal diagnosis
rates and pregnancy outcome.
Design Population-based prevalence study based on EUROCAT
congenital anomaly registries.
Setting Eight European countries.
Population 14.8 million births 1990–2009; 2.89% multiple births.
Methods DS cases included livebirths, fetal deaths from 20
weeks, and terminations of pregnancy for fetal anomaly (TOPFA).
Zygosity is inferred from like/unlike sex for birth denominators,
and from concordance for DS cases.
Main outcome measures Relative risk (RR) of DS per fetus/baby
from multiple versus singleton pregnancies and per pregnancy in
monozygotic/dizygotic versus singleton pregnancies. Proportion of
prenatally diagnosed and pregnancy outcome.
Statistical analysis Poisson and logistic regression stratified for
maternal age, country and time.
Results Overall, the adjusted (adj) RR of DS for fetus/babies from
multiple versus singleton pregnancies was 0.58 (95% CI 0.53–
0.62), similar for all maternal ages except for mothers over 44, for
whom it was considerably lower. In 8.7% of twin pairs affected by
DS, both co-twins were diagnosed with the condition. The adjRR
of DS for monozygotic versus singleton pregnancies was 0.34
(95% CI 0.25–0.44) and for dizygotic versus singleton pregnancies
1.34 (95% CI 1.23–1.46). DS fetuses from multiple births were
less likely to be prenatally diagnosed than singletons (adjOR 0.62
[95% CI 0.50–0.78]) and following diagnosis less likely to be
TOPFA (adjOR 0.40 [95% CI 0.27–0.59]).
Conclusions The risk of DS per fetus/baby is lower in multiple
than singleton pregnancies. These estimates can be used for
genetic counselling and prenatal screening.
Keywords Concordance, Down syndrome, monozygotic and
dizygotic pregnancies, multiple births, pregnancy outcomes, twins.
Please cite this paper as: Boyle B, Morris JK, McConkey R, Garne E, Loane M, Addor MC, Gatt M, Haeusler M, Latos-Bielenska A, Lelong N, McDonnell R,
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Introduction
Prenatal screening for Down syndrome (DS) uses maternal
age-specific risk estimates combined with biochemical and/
or ultrasound measurements to inform the decision
whether to proceed to more invasive diagnostic tests. Lack
of precise and maternal age-specific information regarding
the risk of DS in multiple pregnancies1–3 potentially leads
to misleading risk estimates. Amniocentesis is technically
more difficult to carry out in multiple than in singleton
pregnancies, with a potential risk of sampling the wrong
fetus in discordant dizygotic pregnancies and incurring
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Epidemiology
greater fetal loss.2 The excess risk of fetal loss following
amniocentesis in multiple pregnancies is known to be more
than double that in singleton pregnancies,1,4 but it is not
known how much the risk increases for monozygotic and
dizygotic pregnancies separately.5 Weighing the benefits
and risks of such a procedure should depend on a solid
evidence base.
A number of studies have reported a lower risk of DS in
multiple births relative to singletons6–9 but this finding has
not been reported universally, with some studies finding no
statistical difference in risk.10–12 Nevertheless, the risk per
fetus suggested for genetic counselling is taken by some
investigators as similar in multiple and singleton pregnan-
cies, with the caveat that in monozygotic multiple pregnan-
cies both fetuses would be affected.2,13,14 Others propose that
the risk per pregnancy is more appropriate in genetic coun-
selling and, in recognition of the evidence of a lower than
expected risk per fetus in multiple pregnancies, suggest that
the risk for a twin pregnancy should be given as similar to
the risk in singleton pregnancies.1,15 Recent NICE guide-
lines recommended counselling that the risk of DS per
pregnancy should be considered higher in multiple preg-
nancies, without specifying how much higher.16 French
guidelines recommend using singleton risk estimate tables
without clearly addressing the pregnancy fetus issue.17
The prevalence of DS has increased in association with
an increase in average maternal age over the past two dec-
ades.18,19 The prevalence of multiple births, particularly
dizygotic pregnancies, has also increased in association
both with increasing maternal age and with the use of
assisted reproductive technologies (ART).20–22 The risk of
Down syndrome specifically in monozygotic and in dizy-
gotic pregnancies, as opposed to multiple pregnancies in
general, has not been reported.
Using data from EUROCAT, a network of European
population-based registries of congenital anomaly, we pre-
viously demonstrated a lower than expected risk of chro-
mosomal anomalies in babies from multiple births
compared with singletons in 1990–2009, with the difference
increasing over time.20 The purpose of this paper is to
determine the maternal age-specific prevalence of DS in
monozygotic and in dizygotic pregnancies, and to explore
the risk for each relative to singleton pregnancies. The
paper will also compare prenatal diagnosis and outcome of
pregnancy (livebirths, stillbirths or termination of preg-
nancy) for DS fetuses in multiple and singleton pregnan-
cies.
Methods
European Surveillance of Congenital Anomalies (EURO-
CAT) is a network of population-based registries of
congenital anomaly in 21 countries of Europe. EUROCAT
collects standardised data that can be used to assess
changes in the epidemiology of congenital anomalies and
associated risk factors.23,24 Only DS cases were used in this
analysis. The methods of registry case ascertainment are
fully described elsewhere.19,25 The database includes live
born congenital anomaly cases (LB), stillborn cases and
fetal deaths after 20 weeks’ gestation (FD), and prenatally
diagnosed cases resulting in termination of pregnancy for
fetal anomaly (TOPFA).
Affiliated to EUROCAT is The National Down Syn-
drome Cytogenetic Register (NDSCR), a registry which
does not routinely contribute case data to the EUROCAT
central database but supplied such data specifically for this
study. The NDSCR ascertains all cases of DS from cytoge-
netic reports sent directly from all laboratories in England
and Wales.18 For this study we used all reports in this data-
base of LB and FD from 20 weeks’ gestational age and
TOPFA. The NDSCR data replaced the data of five British
regional EUROCAT registries.
Criteria for inclusion of other EUROCAT registries in the
study were that they should ascertain ≥80% of DS cases
according to the EUROCAT DS data quality indicator (DQI)
2005–2009,26 they should have complete data on multiple
birth status for DS cases, and >80% completeness for mater-
nal age for DS cases, and they should be able to provide data
on population births by multiple birth status and maternal
age. Ten registries (including the NDSCR, which represented
87% of the study population) in eight countries participated
in this study (Table 1). The total study population was
14 827 105 births between 1990 and 2009, of which 2.89%
were from multiple births. Individual fetuses/babies affected
with DS from multiple and singleton pregnancies are
referred to as cases. Twin pairs where both co-twins have DS
are considered ‘concordant’ pairs, and the pregnancy is
assumed to be monozygotic for same sex co-twins and dizy-
gotic for different sex co-twins. We found three concor-
dant pairs of unlike sex. Two same-sex concordant pairs
where one co-twin was dead at amniocentesis and the
other was a TOPFA, were included as monozygotic preg-
nancies but only the co-twin who was a TOPFA was
included as a case. We did not have information on the
sex of unaffected co-twins in non-concordant pairs.
Denominator data on all births by both maternal age
(<20, by 5-year age groups to >44) and multiple birth sta-
tus were available from all 10 registries (see Table 1).The
Office of National Statistics (ONS) for England and Wales
(for NDSCR) and four registries outside the UK were able
to provide denominator data by maternal age and like and
unlike sex (see Table 1), covering 94.4% of our data. In
total, 66.4% of twin pairs were like sex in the UK, and
66.0% outside the UK. Zygosity proportions were
calculated using the Weinberg rule: DZ pairs = 2 (unlike
sex pairs) and MZ pairs = all pairs – (DZ pairs).27,28 This
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Down syndrome in multiple births
meant that denominator data could be estimated for single-
ton, dizygotic and monozygotic twin deliveries. This was
done for data from England and Wales, and for the com-
bined data of the four non-UK countries for the years
available, extrapolated to all seven non-UK countries for
each 10-year period. When these denominators were used
to estimate risk from monozygotic and dizygotic pregnan-
cies relative to singletons, only DS cases from singleton and
twin pregnancies were included, excluding cases from
higher order multiple births (one case from each of 12 trip-
let pregnancies, all from England and Wales). These cases
who were triplets were also excluded when concordance
was estimated.
The ONS also supplied denominators for England and
Wales by single year of maternal age for singleton and mul-
tiple births which were used for an additional analysis of
the NDSCR data. All data were used for all the analyses
unless otherwise stated.
Outcome of pregnancy was available for all EUROCAT
cases. For NDSCR, 3.36% of cases for which outcomes
were missing were excluded from the outcomes analysis
only. Analysis of outcome of pregnancy was confined
to 2000–2009, as this represents the most recent data.
Data on early neonatal survival were not available for all
NDSCR cases, so perinatal death rates could not be
calculated.
Multiple birth is defined for cases in EUROCAT guide-
lines according to the ‘number of babies/fetuses delivered’24
and this definition was also used for ‘multiple pregnancy’
in this study. In the case of DS TOPFA where there was a
selective feticide rather than a full termination of preg-
nancy, it is possible that the civil registration of the unaf-
fected twin was as a singleton despite their classification as
multiple in this study.
Statistical analysis
Statistical analyses were performed using STATA version
9.0 (Statacorp LP, College Station, TX, USA).
Weights representing the probability of fetal survival to
20 weeks’ GA19 were applied to each TOPFA/selective feti-
cide case. They were based on gestational age at TOPFA/
selective feticide in order to standardise the number of
cases and prevalence to 20 weeks’ gestational age, and thus
correct total prevalence rates for any artefact caused by
screening-related differences.
‘Total prevalence of DS cases from multiple pregnancies
per 10 000 births’ was calculated as:
Number of DS cases (LB + FD + TOPFA) which were
from multiple pregnancies corrected to 20 weeks’gestational
age ð10000Þ
Total number of babies (LB + SB) in the population
Total prevalence of DS cases per 10 000 multiple births
was calculated as:
Number of DS cases (LB + FD + TOPFA) which were
frommultiple pregnancies corrected to 20 weeks’gestational
age ð10000Þ
Total number of multiple births (LB + SB) in the population
Similar definitions apply to singleton prevalence of DS.
For monozygotic and dizygotic pregnancy-based analyses,
cases and births are replaced with pregnancies in both
numerator and denominator. A pregnancy is considered to
be ‘affected’ when at least one co-twin is a DS case.
Relative risks (RR) with 95% confidence intervals (95%
CI) were estimated using Poisson regression to represent
the ratio of the prevalence of cases (or affected pregnan-
cies) with DS among multiple births relative to the preva-
lence among singleton births. Poisson regression was used
due to the rarity of the events studied and possibility of no
events happening within a given time period.29 All RRs
were adjusted for country and time period (1990–99 versus
2000–2009). Where stated, RRs were additionally adjusted
for maternal age (grouped by 5-year intervals as described
above for denominators). Logistic regression was used for
analysis of prenatal diagnosis and pregnancy outcomes
(2000–2009) based on cases only, and these analyses were
adjusted for country and, where stated, for maternal age.
The Concordance proportion, calculated for twins only,
was calculated as:
Pairs where both babies or fetuses were DS cases 100
Number of twin pairs from which at least one DS case
was diagnosed
Results
The proportion of older mothers (35 years and over) giving
birth to singletons and to multiples increased in the 2000s
from the preceding decade in nearly all countries
(Figure 1). From 1990 to 1999, the total corrected preva-
lence of DS cases from multiple pregnancies per 10 000
births was 0.40 (95% CI 0.36–0.45), rising to 0.47 (95% CI
0.42–0.53) in 2000–2009 (P > 0.05). Overall (1990–2009)
the prevalence of DS cases per 10 000 multiple births was
15.1 (95% CI 14.6–15.9) and prevalence of DS cases per
10 000 singleton births was 20.1 (95% CI 19.9–20.3). The
prevalence of DS cases per 10 000 multiple births rose with
maternal age up to 44 years but was always lower than the
equivalent maternal age-specific DS prevalence among sin-
gletons (Table 2). This finding was consistent across the
two datasets used (Figure 2). The relative risk of DS for
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Figure 1. Proportion (%) of mothers aged >35 by multiple/singleton birth status according to time period (1990–99, 2000–2007/9) and country.
Table 2. Prevalence of DS cases, adjusted to 20 weeks’ gestation, from multiple and singleton births per 10 000 births and relative risk of DS
cases from multiple births relative to singleton births for two time periods, 10 EUROCAT registries
Time Maternal
age group
DS cases
from multiple
births n
Total prevalence of
DS per 10 000
multiple births
(95% CI)
DS cases
from singleton
births n
Total prevalence of
DS cases per 10 000
singleton births
(95% CI)
RR multiple
versus singleton
(95% CI)
1990–99 <20 0 0 341 6.86 (6.17–7.62) 0 0
20–24 10 3.45 (1.85–6.43) 1119 7.35 (6.93–7.80) 0.46 (0.25–0.87)
24–29 35 5.39 (3.95–7.67) 2231 9.08 (8.71–9.47) 0.60 (0.43–0.84)
30–34 82 11.9 (9.55–14.7) 3189 16.0 (15.5–16.6) 0.74 (0.59–0.92)
35–39 116 36.9 (30.8–44.2) 4061 53.7 (52.0–55.3) 0.69 (0.57–0.82)
40–44 59 133 (103–172) 2517 189 (182–196) 0.70 (0.54–0.91)
>44 0 0 229 357 (313–406) 0 0
Total 302 14.8 (13.2–16.6) 13 686 18.5 (18.2–18.8) 0.66* (0.59–0.74)
2000–2009 <20 3 4.61 (1.49–14.3) 297 6.19 (5.52–6.93) 0.74 (0.24–2.31)
20–24 11 4.16 (2.30–7.52) 905 6.60 (6.19–7.05) 0.63 (0.35–1.14)
24–29 33 6.20 (4.40–8.73) 1600 8.14 (7.75–8.55) 0.76 (0.54–1.07)
30–34 68 8.68 (6.84–11.0) 3398 16.2 (15.6–16.7) 0.54 (0.42–0.68)
35–39 173 33.6 (28.9–39.0) 5655 50.1 (48.8–51.4) 0.67 (0.56–0.78)
40–44 59 59.1 (45.7–76.3) 3768 166 (161–172) 0.35 (0.27–0.46)
>44 1 5.95 (0.82–43.1) 333 310 (278–345) 0.02 (0.00–0.14
Total 347 15.3 (13.8–17.0) 15 956 21.8 (21.4–22.1) 0.52* 0.47–0.58
Combined
1990–2009
<20 3 2.37 (0.76–7.35) 638 6.52 (6.04–7.05) 0.36** (0.12–1.13)
20–24 21 3.75 (2.47–5.82) 2024 7.00 (6.70–7.31) 0.54** (0.35–0.83)
24–29 68 5.82 (4.58–7.39) 3831 8.66 (8.39–8.94) 0.67** (0.52–0.85)
30–34 150 10.2 (8.67–11.9) 6587 16.1 (15.7–16.5) 0.63** (0.54–0.74)
35–39 289 34.8 (31.1–39.1) 9716 51.5 (50.5–52.6) 0.68** (0.60–0.76)
40–44 117*** 81.9 (68.4–98.2) 6284*** 175 (170–179) 0.47** (0.39–0.56)
>44 1 4.48 (0.67–35.1) 562 327 (301–356) 0.015** (0.002–0.107)
Total 649 15.1 (14.6–15.9) 29 643*** 20.1 (19.9–20.3) 0.58*** (0.53–0.62)
*Adjusted for maternal age.
**Adjusted for time.
***As all numbers of cases are adjusted to the number expected at 20 weeks’ gestation and have been rounded up to whole numbers, the
combined 1990–2009 number is not exactly equal to the addition of 1990–199 and 2000–2009.
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babies from multiple births relative to those from singleton
births, adjusted for maternal age, was 0.58 (95%
CI 0.53–0.62). Within the 40–44-year maternal age group,
DS prevalence per 10 000 multiple births was significantly
lower in the 2000s than in the 1990s (P < 0.01, Table 2).
Of the 19 397 babies born to mothers over 44 years of
age, 2043 (10.5%) were from multiple births. In this mater-
nal age group, only one fetus from a multiple pregnancy
was a DS case, a prevalence of 4.48 (95% CI 0.67–35.1) per
10 000 multiple births, compared with 562 singleton DS
cases: a prevalence of 327 (95% CI 301–356) per 10 000
singleton births (Table 2 – RR 0.015 [95% CI 0.002–
0.107]). Based on the number of multiple births in the >44
age group and the singleton DS prevalence in this age
group, the expected number of DS cases from multiple
births would have been 55.
When the NDSCR data were analysed using single year
of maternal age for mothers 35 years and over, the reduced
risk in DS cases from multiple births was more apparent
and further reduced in the 2000s compared with the 1990s
(Figure 3; also see Table S1). There was also a slight
decrease in DS prevalence among singleton births over the
two time periods.
In 8.7% (n = 54) of affected pairs the co-twins were
concordant for DS, 51 same sex twin pairs (assumed to be
monozygotic) and three unlike sex twin pairs. When analy-
ses were carried out for monozygotic and dizygotic preg-
nancies separately, the maternal age-adjusted relative risk of
a monozygotic pregnancy being affected was 0.34 (95% CI
0.25–0.44) compared with singleton pregnancies (Table 3).
There were no affected monozygotic twin pregnancies in
the >44-year maternal age group and the relative risk did
not vary significantly by maternal age for mothers under 45
(P > 0.05; Table 3). For dizygotic pregnancies, the maternal
age adjusted relative risk of at least one co-twin being
affected was 1.34 (95% CI 1.23–1.46) compared with sin-
gleton pregnancies. The relative risk dropped after maternal
age 44 to RR 0.04 (95% CI 0.01–0.27). There was no statis-
tically significant variation in relative risk between maternal
ages 20 and 44 (Table 3; P > 0.05). The adjusted relative
risk excluding the over 44-year maternal age group is
unchanged compared with the all ages estimate.
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The proportion of DS cases which were prenatally diag-
nosed rose with maternal age for cases from both singleton
and multiple pregnancies (Table 4).The proportion of DS
cases which were prenatally diagnosed was lower for multi-
ple than for singleton pregnancies at all maternal ages
(Table 4), giving an overall maternal age adjusted OR of
0.62 (95% CI 0.50–0.78; Table 4).
A prenatally diagnosed DS case from a multiple preg-
nancy was less likely to result in TOPFA following prenatal
diagnosis than was a prenatally diagnosed DS case from a
singleton pregnancy: maternal age adjusted OR 0.40 (95%
CI 0.26–0.60; Table 4). The overall proportion of cases
from multiple pregnancies which were TOPFAs was lower
than singletons at every maternal age, giving an overall
maternal age adjusted OR of 0.52 (95% CI 0.41–0.65;
Table 4).
Overall, DS cases from multiple births were not more
likely to be stillbirths/FD than from singleton births (after
excluding TOPFAs): maternal age adjusted OR 1.03 (95%
CI 0.59–1.78; Table 4). In the NDSCR data there were 204
fetuses from singleton and eight from multiple pregnancies
who were prenatally diagnosed but miscarried naturally
before 20 weeks’ gestation and so were not included as
cases in the main analyses. Of those eight from multiple
pregnancies, two had an affected co-twin who became
TOPFA and six had an unaffected co-twin. Overall, 3.8%
of prenatally diagnosed fetuses who miscarried before
20 weeks were from multiple pregnancies.
Discussion
Main findings
Our results showing that fetus/babies from multiple preg-
nancies had 58% of the risk of DS than those from single-
ton pregnancies, after accounting for maternal age, strongly
support the reports of a lower prevalence of DS in multiple
relative to singleton births in several early studies.6–8 Sev-
eral more recent studies10,11 found a similar risk in multi-
ple births and singletons, but this may because their data
only included livebirths, and a higher proportion of their
singleton cases than their cases from multiple pregnancies
may have proceeded to TOPFA and so been excluded from
their studies, thus reducing the difference in risk. The other
study finding a similar risk was very small.12 Fetus/
baby-specific and pregnancy-specific risk estimates should
be distinguished. In a dizygotic pregnancy, each co-twin
has an individual risk of being a DS case and so the preg-
nancy-specific risk is almost twice the fetus/baby-specific
risk. We estimated that dizygotic pregnancies are one-third
more likely to have at least one DS case than their single-
ton counterparts after accounting for maternal age, much
lower than the expected doubling of singleton risk. For a
monozygotic pregnancy, the pregnancy-specific and
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fetus-specific risks are the same, but the former involves
two affected fetuses rather than one. We found the preg-
nancy-specific risk of DS for monozygotic pregnancies to
be one-third of the singleton risk.
With our large study population, we were also able to
establish that the lower than expected number of DS cases
is observed at all maternal ages up to 44. Over the age of
44 it becomes very rare for a mother of a multiple birth to
have a baby diagnosed with Down syndrome.
We found that the lower than expected prevalence of DS
related particularly to monozygotic twins, and this is sup-
ported by the low proportion of concordant pairs: 8.7%
rather than the approximately 27% which would be
expected if the ratio of monozygotic to dizygotic pairs was
the same for DS cases from multiple pregnancies as the
ratio in the birth population.
Prenatal diagnosis and TOPFA/selective feticides were
less common for DS in multiple than singleton pregnan-
cies.
Interpretation
A partial explanation for the very low risk of DS to moth-
ers over 44 may be that these mothers are the most likely
to have become pregnant through ART using either their
own frozen or donor eggs, created at an earlier age than
their age at the index pregnancy, giving them a risk which
is lower than their age would suggest.30,31 Our risk esti-
mates for women over 44 may therefore be underestimates
for those naturally conceiving. It is likely that this also
explains the increasing difference over time in DS risk
between singletons and multiples for mothers in the 40–
44-year age group. An obvious implication is that prenatal
screening should make reference to the age of the mother/
donor at the time the egg was harvested, rather than the
mother’s age at the time of the current pregnancy. Use of a
previously frozen egg/embryo would be more frequent with
single embryo transfer policies, making this issue also
pertinent to singleton pregnancies. Currently, preimplanta-
tion diagnosis and selection is rare, but in future this may
also lower the prevalence of DS in multiple births from
ART. As embryos with chromosomal anomalies are
believed to be more fragile than their counterparts without
chromosomal anomalies,32,33 one can also speculate that
embryos without chromosomal anomalies tend to be cho-
sen for implantation, even when no formal preimplantation
diagnosis is performed, as they appear more robust during
the ART process. ART (e.g. via ovarian stimulation) has
been suggested as a possible risk factor for DS, but a recent
study has not supported this34 and although we could not
directly test this without data on the use of ART, there is
nothing in our results to support this.
However, ART is not an explanation for the lower DS risk
in multiples across all maternal ages, and the lower DS risk
in monozygotic than dizygotic pregnancies. The most likely
explanation is early fetal loss of DS in multiple pregnancies,
particularly in pregnancies concordant for DS. Multiple
pregnancy could be seen as co-morbidity, which makes it less
likely for the DS-affected fetuses to survive to diagnosis. We
postulate that at all maternal ages, but especially for those
aged over 44 years, either the affected embryos/fetuses are
too fragile to survive or one co-twin has been lost in very
early pregnancy so that the remaining affected fetus is per-
ceived to be a singleton. The literature speculates on a ten-
dency for the unaffected twin of a dizygotic pair to be able to
improve the survival chances of the affected twin35 This pos-
sibility is not borne out by our data, as the prevalence of DS
cases from dizygotic multiple pregnancies is lower than that
observed in singletons. The fragility of DS embryos/fetuses
and vulnerability to stressors is supported by literature impli-
cating low folate levels36 coffee and alcohol consumption
and perhaps smoking with very early loss of the DS embryo.
In the context of multiple pregnancy as a stressor,37,38 the
higher survival of DS in dizygotic than monozygotic pairs
may reflect the increased stress involved in carrying two DS
cases in one pregnancy, combined with the increased delicacy
of monochorionic relative to dichorionic pairs39 When one
of a monozygotic concordant pair dies, the other is less likely
to survive, as a result of their shared placenta.
The lower rates of prenatal diagnosis and TOPFA/selec-
tive feticides for DS in multiple than singleton pregnancies
reflect in part the increased difficulty of the screening and
diagnostic procedures. In addition to the technical difficul-
ties involved in the procedures, prenatal diagnosis can pres-
ent professionals and families with very difficult decisions,
particularly in discordant pairs where there is an unaffected
co-twin whose welfare must also be factored into decisions
regarding selective feticide40 Although it is reported that
women who have achieved pregnancy through ART are less
likely to consent to invasive procedures,13 there is also
anecdotal evidence that the decision to have a selective feti-
cide is easier rather than harder for those women who have
accessed ART procedures and have already had to make
potentially difficult decisions about their fertility41 Where
selective feticide is chosen, survival of the unaffected twin
increases when the procedure is carried out in the first tri-
mester of pregnancy,2 suggesting that reliable screening
should be carried out as early as possible.
Strengths and limitations
The strengths of this study are the very large population size
using standard definitions, with the ability thereby to stratify
by maternal age and replicate results across two different types
of registry. The weaknesses are that zygosity/chorionicity is
not known and can only be inferred, and that ART is not
known for the majority of cases and therefore could not be
analysed. Therefore the zygosity-specific results must be trea-
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ted as estimates. We considered same sex concordant pairs as
monozygotic, but the three observed dizygotic different sex
concordant DS pairs suggest that approximately three of the
same sex concordant pairs might also be dizygotic. If we had
reallocated these pairs, the adjusted risk of at least one co-twin
in a dizygotic pair being affected relative to a singleton would
have been essentially unchanged but the adjusted risk of both
co-twins in a monozygotic pair relative to a singleton being
affected would have been slightly smaller.
Risk estimates have been corrected to 20 weeks’ gesta-
tional age, which would be lower than the prevalence/risks
in the first trimester of pregnancy, when DS is often diag-
nosed and decisions regarding TOPFA/selective feticide are
made.
Conclusions
Individual fetuses from multiple pregnancies, whether
monozygotic or dizygotic, are at less risk of DS than those
from singleton pregnancies. The overall risk of a dizygotic
pregnancy being affected by DS (one or both fetuses) is
about a third higher than a singleton pregnancy at all
maternal ages up to 44. The risk of DS in monozygotic
multiple pregnancies is approximately one-third of the risk
in singleton pregnancies for a mother of similar age
although both fetuses will be affected. Twin pregnancies in
mothers over 44 have a very low risk of DS.
Our estimates of the lower maternal age-specific DS risk
in multiple pregnancies, when combined with the clini-
cian’s knowledge of zygosity/chorionicity and maternal age
at ovulation in the case of ART for individual women,
should allow more accurate risk estimates to be used in
genetic counselling and prenatal screening.
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Down syndrome in multiple births
Mini commentary on ‘Prevalence and risk of Down Syndrome
in monozygotic and dizygotic multiple pregnancies in Europe:
implications for prenatal screening’
ME Norton
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of
California, San Francisco, San Francisco, CA, USA
Twin gestations now make up
approximately 3% of births in the
USA, and a comparable number in
other developed countries. Given
that the highest rate of increase has
been seen in older mothers, accurate
data regarding the risk of aneu-
ploidy, the effectiveness of prenatal
aneuploidy screening, and the risks
of invasive diagnostic procedures are
increasingly important.
Decisions regarding prenatal
genetic testing in twins are complex
for several reasons. The risk of aneu-
ploidy is increased, based on the
greater average maternal age, and is
assumed to be nearly double for the
pregnancy due to the risk for two
fetuses. The background risk of preg-
nancy loss is higher in multiple ges-
tations. Serum aneuploidy screening
is less accurate in twins (Gar-
chet-Beaudron A et al. Prenat Diagn
2008;28:1105–9), data on use of non-
invasive prenatal testing remains lim-
ited (Canick JA et al. Prenat Diagn
2012;32:730–4), and the risk of pro-
cedure-related miscarriage following
invasive diagnostic testing is not well
documented (Agarwal et al. Ultrasound
Obstet Gynecol 2012;40:128–34).
For these reasons, the data that we
use to counsel patients regarding
prenatal aneuploidy testing in single-
tons do not apply to twins. Key to
prenatal genetic counseling is accu-
rate knowledge of a priori risk of an
affected fetus. This is important for
women deciding about testing and
also a component of multiple-marker
screening risk algorithms. Although
there is substantial data supporting
the maternal age-based risks for
chromosome abnormalities in single-
tons, there are limited data for twins.
Many centres quote a ‘per fetus’ risk,
assuming each twin has a risk com-
parable to a singleton at the same
maternal age. Some centres use a
formula that accounts for a percent-
age of monozygotic twins, but most
quote risks based on such modeling
rather than accumulated data.
Interestingly, some small studies
have suggested that the risk of aneu-
ploidy in twins is significantly lower
than in singletons (Jamar M et al.
Genet Couns 2003;14:395–400). The
report in this edition of BJOG con-
firms these findings in a large popu-
lation-based study. They found that
the risk of Down syndrome in mono-
zygotic twins was about one third of
that in singletons, whereas the risk in
dizygotic twins was about one third
higher than in singletons – increased,
but substantially less than the dou-
bling of risk that is often used in
counseling of pregnant patients (Boy-
le et al. BJOG).
Although not intuitive, these find-
ings are certainly biologically plausi-
ble. The authors note that fetal loss
can occur due to multiple ‘hits’, and
that monochorionic placentation,
older maternal age, and twinning all
increase the risk of pregnancy loss, as
does aneuploidy. In pregnancies in
which multiple risk factors are pres-
ent, the chance of a Down syndrome
pregnancy surviving is decreased. This
paper provides not just important
data on aneuploidy risks in twin ges-
tations but is also humbling as regards
assumptions that we make that seem
entirely reasonable but that are just
that – opinions that may or may not
be ultimately supported by data. Here,
at last, are data useful in counseling
our patients carrying twin gestations.
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